top
Search terms
Results 1 - 10 of 19 - ordered by :
Pages: 1 2
Ejhf

Serum aldosterone is associated with mortality and re‐hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial Introduction ...

European Journal of Heart Failure, Girerd, Nicolas, Pang, Peter S., Swedberg, Karl, Fought, Angela, Kwasny, Mary J., Subacius, Haris, Konstam, Marvin A., Maggioni, Aldo, Gheorghiade, Mihai, Zannad, ...

Date : 01/11/2013 Item size : 177224 bytes
Ejhf

Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial Introduction Optimal heart failure therapy in patients with reduced left ...

European Journal of Heart Failure, Kiernan, Michael S., Wentworth, Deborah, Francis, Gary, Martinez, Felipe A., Dickstein, Kenneth, Komajda, Michel, Zannad, Faiez, Neaton, James D., Konstam, Marvin A.

Date : 01/12/2012 Item size : 173079 bytes
Ejhf

Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial Introduction In the last ...

European Journal of Heart Failure, Mentz, Robert J., Allen, Bradley D., Kwasny, Mary J., Konstam, Marvin A., Udelson, James E., Ambrosy, Andrew P., Fought, Angela J., Vaduganathan, Muthiah, O'Connor, ...

Date : 01/01/2013 Item size : 177809 bytes
Ejhf

Introduction Following hospitalization for acute heart failure (HF) syndromes, patients are at a significantly increased risk for adverse outcomes, with mortality rates as high as 10% and ...

European Journal of Heart Failure, Dunlay, Shannon M., Gheorghiade, Mihai, Reid, Kimberly J., Allen, Larry A., Chan, Paul S., Hauptman, Paul J., Zannad, Faiez, Maggioni, Aldo P., Swedberg, Karl, ...

Date : 01/04/2010 Item size : 192467 bytes
Ejhf

[2, 3] Hospitalizations are responsible for the majority of costs of care related to HF, leading to the United States Center for Medicare and Medicaid Services (CMS) mandate to report hospital-level ...

European Journal of Heart Failure, Khan, Hassan, Greene, Stephen J., Fonarow , Gregg C., Kalogeropoulos, Andreas P., Ambrosy, Andrew P., Maggioni, Aldo P., Zannad, Faiez, Konstam, Marvin A., ...

Date : 01/10/2015 Item size : 189089 bytes
Ejhf

The Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial[11]−[13] provides a unique opportunity to perform an in-depth characterization of LFTs during ...

European Journal of Heart Failure, Ambrosy, Andrew P., Vaduganathan, Muthiah, Huffman, Mark D., Khan, Sadiya, Kwasny, Mary J., Fought, Angela J., Maggioni, Aldo P., Swedberg, Karl, Konstam, Marvin ...

Date : 01/03/2012 Item size : 189922 bytes
Ehjournal

Introduction Acute heart failure syndromes (AHFS), defined as rapid development of signs and symptoms of heart failure (HF) are a major public health problem, accounting for over 1.1 million ...

European Heart Journal, Blair, John E.A., Khan, Sadiya, Konstam, Marvin A., Swedberg, Karl, Zannad, Faiez, Burnett, John C., Grinfeld, Liliana, Maggioni, Aldo P., Udelson, James E., Zimmer, ...

Date : 01/07/2009 Item size : 250975 bytes
Ehjournal

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the ...

European Heart Journal, Ambrosy, Andrew P., Pang, Peter S., Khan, Sadiya, Konstam, Marvin A., Fonarow, Gregg C., Traver, Brian, Maggioni, Aldo P., Cook, Thomas, Swedberg, Karl, Burnett, John C., ...

Date : 14/03/2013 Item size : 289621 bytes
Ehjournal

Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges The use of vitamin K antagonists is more unstable in patients with concomitant AF ...

European Heart Journal, Ferreira, João Pedro, Girerd, Nicolas, Alshalash, Saleh, Konstam, Marvin A., Zannad, Faiez

Date : 14/08/2016
Ehjournal

Methods and results Of the 4133 patients hospitalized with worsening HF and reduced left ventricular ejection fraction (LVEF) (40%) in the EVEREST trial, 2072 were randomized to tolvaptan, a ...

European Heart Journal, Blair, John E.A., Pang, Peter S., Schrier, Robert W., Metra, Marco, Traver, Brian, Cook, Thomas, Campia, Umberto, Ambrosy, Andrew, Burnett, John C., Grinfeld, Liliana, ...

Date : 01/10/2011 Item size : 327049 bytes